ALX Oncology Holdings ALXO 深 滬
等待開盤 04-02 09:30:00 美东时间
1.98
-0.025
-1.25%
華盛通- 最 高2.05
- 今 開2.04
- 成交量 38.01万股
- 最 低 1.965
- 昨 收 2.005
- 總市值 2.61亿
- 52周最高 2.66
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.404
- 委 比 -26.31%
- 總股本 1.32亿
- 歷史最高 117.45
- 量 比 0.62
- 振 幅 4.24%
- 歷史最低 0.404
- 每 手 1
- 風險率 0.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5
Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $5.
03-19 21:02
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $4 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintains $4 price target.
03-10 19:38
ALX Oncology Holdings shares are trading lower after the company reported worse-than-expected Q4 EPS results.
ALX Oncology Holdings shares are trading lower after the company reported worse...
02-27 23:36
ALX Oncology Holdings Q4 Adj. EPS $(0.37) Misses $(0.36) Estimate
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.36) by 2.21 percent. This is a 15.91 percent increase over losses of $(0.44) per share
02-27 22:03
ALX Oncology GAAP EPS of -$0.42 misses by $0.06
ALX Oncology press release (ALXO): Q4 GAAP EPS of -$0.42 misses by $0.06. Net loss of $22.85M. More on ALX Oncology ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Con...
02-27 21:35
Earnings Scheduled For February 27, 2026
Companies Reporting Before The Bell • Escalade (NASDAQ:ESCA) is estimated to re...
02-27 19:11
ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference
ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference ALX Oncology Holdings Inc. will participate in the Wells Fargo Executive Biotech Summit (one-on-one meetings) on Feb. 24–25, 2026 in Lake Tahoe, California; present at the TD Cowen 46th Annual Health Care Conference on
02-19 21:33
ALX Oncology Holdings Inc. published an update to their financial calendar
ALX Oncology Holdings Inc. published an update to their financial calendar ALX Oncology Holdings Inc. will report fourth-quarter and full-year 2025 financial results and provide a business update on February 27, 2026, before market open; the results will be released via a financial results press rel
02-19 21:31
